• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 TIGIT 在免疫经验丰富的宿主与以前未致敏的宿主中的败血症生存中产生差异影响。

Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts.

机构信息

Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.

Department of Critical Care Medicine, The First Affiliated Hospital of China Medical University, China Medical University, Shenyang, China.

出版信息

JCI Insight. 2021 Mar 8;6(5):141245. doi: 10.1172/jci.insight.141245.

DOI:10.1172/jci.insight.141245
PMID:33682797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8021109/
Abstract

Mounting evidence suggests that the balance of T cell costimulatory and coinhibitory signals contributes to mortality during sepsis. Here, we identified a critical role of the coinhibitory molecule T cell Ig and ITIM domain (TIGIT) in regulating sepsis mortality. Because TIGIT is significantly upregulated on memory T cells, we developed a "memory mouse" model to study the role of TIGIT during sepsis in a more physiologically relevant context. Mice received sequential pathogen exposure and developed memory T cell frequencies, similar to those observed in adult humans, and were then subjected to sepsis induction via cecal ligation and puncture. Our results show that targeting the TIGIT pathway during sepsis is fundamentally different in previously naive versus memory mice, in that αTIGIT Ab had no effect on survival in previously naive septic mice but sharply worsened survival in memory septic mice. Mechanistically, αTIGIT increased apoptosis of memory T cells, decreased T cell function, and downregulated the costimulatory receptor DNAM on memory CD8+ T cells in memory septic mice, but not in previously naive septic mice. Additionally, αTIGIT diminished Helios expression in Tregs in memory but not previously naive septic mice. These data highlight fundamental differences in the pathophysiological impact of targeting TIGIT in immunologically experienced versus previously naive hosts during sepsis.

摘要

越来越多的证据表明,T 细胞共刺激和共抑制信号的平衡有助于脓毒症患者的死亡率。在这里,我们确定了共抑制分子 T 细胞免疫球蛋白和 ITIM 结构域(TIGIT)在调节脓毒症死亡率方面的关键作用。由于 TIGIT 在记忆 T 细胞上显著上调,我们开发了一种“记忆小鼠”模型,以在更具生理相关性的背景下研究 TIGIT 在脓毒症中的作用。小鼠接受连续的病原体暴露并发展出记忆 T 细胞频率,类似于在成年人类中观察到的频率,然后通过盲肠结扎和穿刺诱导脓毒症。我们的结果表明,在以前未接触过的和记忆小鼠中,针对 TIGIT 通路的治疗在脓毒症中存在根本差异,因为 αTIGIT Ab 对以前未接触过的脓毒症小鼠的存活没有影响,但在记忆脓毒症小鼠中却明显恶化了存活。从机制上讲,αTIGIT 增加了记忆 T 细胞的凋亡,降低了记忆脓毒症小鼠 T 细胞的功能,并下调了记忆 CD8+T 细胞上的共刺激受体 DNAM,但在以前未接触过的脓毒症小鼠中没有。此外,αTIGIT 在记忆而非以前未接触过的脓毒症小鼠中降低了 Treg 中的 Helios 表达。这些数据突出了在脓毒症中,针对免疫经验丰富与以前未接触过的宿主中的 TIGIT 的治疗在病理生理学方面的根本差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/38b388bc6cf5/jciinsight-6-141245-g189.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/68866541d592/jciinsight-6-141245-g183.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/45e75108d17f/jciinsight-6-141245-g184.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/0c38da3de3cd/jciinsight-6-141245-g185.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/c3667a66caf6/jciinsight-6-141245-g186.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/f5d7d9aa5bf4/jciinsight-6-141245-g187.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/278190997b4d/jciinsight-6-141245-g188.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/38b388bc6cf5/jciinsight-6-141245-g189.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/68866541d592/jciinsight-6-141245-g183.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/45e75108d17f/jciinsight-6-141245-g184.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/0c38da3de3cd/jciinsight-6-141245-g185.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/c3667a66caf6/jciinsight-6-141245-g186.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/f5d7d9aa5bf4/jciinsight-6-141245-g187.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/278190997b4d/jciinsight-6-141245-g188.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ac/8021109/38b388bc6cf5/jciinsight-6-141245-g189.jpg

相似文献

1
Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts.抗 TIGIT 在免疫经验丰富的宿主与以前未致敏的宿主中的败血症生存中产生差异影响。
JCI Insight. 2021 Mar 8;6(5):141245. doi: 10.1172/jci.insight.141245.
2
CD28 Agonism Improves Survival in Immunologically Experienced Septic Mice via IL-10 Released by Foxp3 Regulatory T Cells.CD28 激动剂通过 Foxp3+调节性 T 细胞释放的 IL-10 改善免疫经验性败血症小鼠的存活率。
J Immunol. 2020 Dec 15;205(12):3358-3371. doi: 10.4049/jimmunol.2000595. Epub 2020 Nov 6.
3
Immune checkpoint molecule TIGIT manipulates T cell dysfunction in septic patients.免疫检查点分子 TIGIT 调控脓毒症患者 T 细胞功能障碍。
Int Immunopharmacol. 2021 Dec;101(Pt B):108205. doi: 10.1016/j.intimp.2021.108205. Epub 2021 Oct 13.
4
TIGIT modulates sepsis-induced immune dysregulation in mice with preexisting malignancy.TIGIT 调节患有先前恶性肿瘤的小鼠脓毒症引起的免疫失调。
JCI Insight. 2021 Jun 8;6(11):e139823. doi: 10.1172/jci.insight.139823.
5
CD8 T cells are necessary for improved sepsis survival induced by CD28 agonism in immunologically experienced mice.CD8 T 细胞对于免疫经验丰富的小鼠中 CD28 激动剂诱导的改善脓毒症存活率是必需的。
Front Immunol. 2024 Apr 3;15:1346097. doi: 10.3389/fimmu.2024.1346097. eCollection 2024.
6
Increased attrition of memory T cells during sepsis requires 2B4.脓毒症期间记忆 T 细胞的损耗增加需要 2B4。
JCI Insight. 2019 May 2;4(9). doi: 10.1172/jci.insight.126030.
7
TIGIT regulates CD4 T cell immunity against polymicrobial sepsis.TIGIT 调节 CD4 T 细胞对多微生物脓毒症的免疫。
Front Immunol. 2024 Mar 13;15:1290564. doi: 10.3389/fimmu.2024.1290564. eCollection 2024.
8
CD226 opposes TIGIT to disrupt Tregs in melanoma.CD226 通过拮抗 TIGIT 来破坏黑色素瘤中的 Tregs。
JCI Insight. 2018 Jul 26;3(14). doi: 10.1172/jci.insight.121157.
9
TIGIT predominantly regulates the immune response via regulatory T cells.TIGIT主要通过调节性T细胞来调节免疫反应。
J Clin Invest. 2015 Nov 2;125(11):4053-62. doi: 10.1172/JCI81187. Epub 2015 Sep 28.
10
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.表达受体TIGIT和CD226的人类调节性T细胞的不同表型
J Immunol. 2015 Jul 1;195(1):145-55. doi: 10.4049/jimmunol.1402381. Epub 2015 May 20.

引用本文的文献

1
The Multifaceted Role of Regulatory T Cells in Sepsis: Mechanisms, Heterogeneity, and Pathogen-Tailored Therapies.调节性T细胞在脓毒症中的多方面作用:机制、异质性及病原体针对性疗法
Int J Mol Sci. 2025 Aug 1;26(15):7436. doi: 10.3390/ijms26157436.
2
Tim-3 pathway dysregulation and targeting in sepsis-induced immunosuppression.Tim-3通路失调与脓毒症诱导的免疫抑制中的靶向治疗
Eur J Med Res. 2024 Dec 18;29(1):583. doi: 10.1186/s40001-024-02203-w.
3
TIGIT stimulation suppresses autoimmune uveitis by inhibiting Th17 cell infiltration.

本文引用的文献

1
CD226CD8 T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.CD226CD8 T 细胞是抗 TIGIT 免疫治疗的前提条件。
Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7.
2
TIGIT limits immune pathology during viral infections.TIGIT 限制病毒感染期间的免疫病理。
Nat Commun. 2020 Mar 9;11(1):1288. doi: 10.1038/s41467-020-15025-1.
3
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
TIGIT 刺激通过抑制 Th17 细胞浸润来抑制自身免疫性葡萄膜炎。
J Leukoc Biol. 2024 Nov 4;116(5):1054-1060. doi: 10.1093/jleuko/qiae116.
4
TIGIT regulates CD4 T cell immunity against polymicrobial sepsis.TIGIT 调节 CD4 T 细胞对多微生物脓毒症的免疫。
Front Immunol. 2024 Mar 13;15:1290564. doi: 10.3389/fimmu.2024.1290564. eCollection 2024.
5
The Calm after the Storm: Implications of Sepsis Immunoparalysis on Host Immunity.暴风雨后的平静:脓毒症免疫麻痹对宿主免疫的影响。
J Immunol. 2023 Sep 1;211(5):711-719. doi: 10.4049/jimmunol.2300171.
6
Sepsis-induced changes in differentiation, maintenance, and function of memory CD8 T cell subsets.脓毒症诱导记忆 CD8 T 细胞亚群分化、维持和功能的改变。
Front Immunol. 2023 Jan 23;14:1130009. doi: 10.3389/fimmu.2023.1130009. eCollection 2023.
7
Inflammation Controls Susceptibility of Immune-Experienced Mice to Sepsis.炎症控制免疫经验小鼠对败血症的易感性。
Immunohorizons. 2022 Jul 25;6(7):528-542. doi: 10.4049/immunohorizons.2200050.
8
TIGIT Deficiency Protects Mice From DSS-Induced Colitis by Regulating IL-17A-Producing CD4 Tissue-Resident Memory T Cells.TIGIT 缺乏通过调节产生白介素-17A 的 CD4 组织驻留记忆 T 细胞来保护小鼠免受 DSS 诱导的结肠炎。
Front Immunol. 2022 Jul 1;13:931761. doi: 10.3389/fimmu.2022.931761. eCollection 2022.
9
Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis?调节性 T 细胞:在脓毒症发病机制中是天使还是恶魔?
Front Immunol. 2022 Feb 25;13:829210. doi: 10.3389/fimmu.2022.829210. eCollection 2022.
10
Severity of Sepsis Determines the Degree of Impairment Observed in Circulatory and Tissue-Resident Memory CD8 T Cell Populations.脓毒症的严重程度决定了循环和组织驻留记忆 CD8 T 细胞群体中观察到的损伤程度。
J Immunol. 2021 Oct 1;207(7):1871-1881. doi: 10.4049/jimmunol.2001142. Epub 2021 Sep 3.
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
4
Check Point Inhibitors and Their Role in Immunosuppression in Sepsis.免疫检查点抑制剂及其在脓毒症免疫抑制中的作用。
Crit Care Clin. 2020 Jan;36(1):69-88. doi: 10.1016/j.ccc.2019.08.006. Epub 2019 Oct 21.
5
2B4 but not PD-1 blockade improves mortality in septic animals with preexisting malignancy.2B4 而非 PD-1 阻断可改善合并预先存在恶性肿瘤的脓毒症动物的死亡率。
JCI Insight. 2019 Nov 14;4(22):127867. doi: 10.1172/jci.insight.127867.
6
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab.免疫检查点抑制在脓毒症中的应用:一项评价纳武单抗安全性、耐受性、药代动力学和药效学的 1b 期随机研究。
Intensive Care Med. 2019 Oct;45(10):1360-1371. doi: 10.1007/s00134-019-05704-z. Epub 2019 Oct 1.
7
T Cell- and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer.T 细胞和单核细胞特异性 RNA 测序分析在脓毒症和非脓毒症危重症患者以及癌症患者中的应用。
J Immunol. 2019 Oct 1;203(7):1897-1908. doi: 10.4049/jimmunol.1900560. Epub 2019 Sep 4.
8
Increased attrition of memory T cells during sepsis requires 2B4.脓毒症期间记忆 T 细胞的损耗增加需要 2B4。
JCI Insight. 2019 May 2;4(9). doi: 10.1172/jci.insight.126030.
9
Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike.脓毒症中的免疫佐剂治疗:针对即将出现的免疫抑制性脓毒症的新策略。
Acute Med Surg. 2018 Aug 6;5(4):309-315. doi: 10.1002/ams2.363. eCollection 2018 Oct.
10
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.阻断检查点受体 TIGIT 可防止 NK 细胞耗竭并引发强大的抗肿瘤免疫。
Nat Immunol. 2018 Jul;19(7):723-732. doi: 10.1038/s41590-018-0132-0. Epub 2018 Jun 18.